Angela De Martini
Angela De Martini is a vice president in CRA’s Life Sciences Practice, specializing in pharmaceuticals, medical devices, and medical technology (MedTech). Angela serves clients across a wide range of functions, including commercial, operations, medical affairs, market access, and public affairs. Prior to CRA’s acquisition of C1 Consulting in 2017, she was a director at C1 Consulting and held senior positions at a-Connect and Navigant. She is fluent in Italian and English and has a basic knowledge of German.
CTES, London Business School & University College London
MSc, Biochemical Engineering, University College London
MA, Biotechnology, Università degli Studi di Milano-Bicocca